Shince Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 16 Year, 30 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.97 Cr
as on 17-11-2024
- Satisfied Charges ₹ 1.25 Cr
as on 17-11-2024
- Revenue -67.50%
(FY 2023)
- Profit -63.42%
(FY 2023)
- Ebitda -36.04%
(FY 2023)
- Net Worth 2.75%
(FY 2023)
- Total Assets -4.71%
(FY 2023)
About Shince Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.97 Cr. The company has closed loans amounting to ₹1.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramasamy Krishnamoorthy and Gowri Krishnamoorthy serve as directors at the Company.
- CIN/LLPIN
U24232TN2008PTC069950
- Company No.
069950
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Shince Pharmaceuticals Private Limited offer?
Shince Pharmaceuticals Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs, Common Disease Medicines, Pharmaceutical Medicine, Cardiovascular Drugs & Medication, Diabetes Medicine, Arthritic Drugs, Antianginal Drugs, Pharmaceutical Tablets, Digestive System Drugs & Medicines.
Who are the key members and board of directors at Shince Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramasamy Krishnamoorthy  | Director | 24-Nov-2008 | Current |
| Gowri Krishnamoorthy | Director | 24-Nov-2008 | Current |
Financial Performance of Shince Pharmaceuticals.
Shince Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 67.5% decrease. The company also saw a substantial fall in profitability, with a 63.42% decrease in profit. The company's net worth moved up by a moderate rise of 2.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shince Pharmaceuticals?
In 2023, Shince Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sonivar Pharma Private LimitedActive 1 year 11 monthsRamasamy Krishnamoorthy and Gowri Krishnamoorthy are mutual person
- Surien Pharmaceuticals Private LimitedActive 20 years 8 months
Ramasamy Krishnamoorthy and Gowri Krishnamoorthy are mutual person
- Chennai Jk Studio Technologies Private LimitedActive 8 years 2 months
Ramasamy Krishnamoorthy and Gowri Krishnamoorthy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Sep 2022 | ₹1.01 Cr | Open |
State Bank Of India Creation Date: 04 Sep 2010 | ₹9.60 M | Open |
Karnataka Bank Limited Creation Date: 20 Nov 2009 | ₹1.25 Cr | Satisfied |
How Many Employees Work at Shince Pharmaceuticals?
Unlock and access historical data on people associated with Shince Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shince Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shince Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
